Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,389

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function

Open access
Papadopoulos, Vassilios, Baraldi, Mario, Guilarte, Tomás R., Knudsen, Thomas B., Lacapère, Jean-Jacques, Lindemann, Peter, Norenberg, Michael D., Nutt, David, Weizman, Abraham, Zhang, Ming-Rong, Gavish, Moshe·2006·Trends in Pharmacological Sciences
DOI 10.1016/j.tips.2006.06.005
Open this paper in CoChat — free account

Abstract

The peripheral-type benzodiazepine receptor or recognition site (PBR) is a widely distributed transmembrane protein that is located mainly in the outer mitochondrial membrane. The PBR binds to high-affinity drug ligands and cholesterol. Many functions are associated directly or indirectly with the PBR, including the regulation of cholesterol transport and the synthesis of steroid hormones, porphyrin transport and heme synthesis, apoptosis, cell proliferation, anion transport, regulation of mitochondrial functions and immunomodulation. Based on these functions, there are many potential clinical applications of PBR modulation, such as in oncologic, endocrine, neuropsychiatric and neurodegenerative diseases. Although "PBR" is a widely used and accepted name in the scientific community, recent data regarding the structure and molecular function of this protein increasingly support renaming it to represent more accurately its subcellular role (or roles) and putative tissue-specific function (or functions). Translocator protein (18kDa) is proposed as a new name, regardless of the subcellular localization of the protein.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tips.2006.06.005

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 58

  1. Braestrup, 1977, High densities of benzodiazepine receptors in human cortical areas, Nature, 269, 702, 10.1038/269702a0 · DOI · Paper page
  2. Corsi, 2004, Peripheral benzodiazepine receptors in potatoes (Solanum tuberosum), Biochem. Biophys. Res. Commun., 313, 62, 10.1016/j.bbrc.2003.11.089 · DOI
  3. Lindemann, 2004, A novel Arabidopsis thaliana protein is a functional peripheral-type benzodiazepine receptor, Plant Cell Physiol., 45, 723, 10.1093/pcp/pch088 · DOI
  4. Kinnally, 1993, Mitochondrial benzodiazepine receptor linked to inner membrane ion channels by nanomolar actions of ligands, Proc. Natl. Acad. Sci. U. S. A., 90, 1374, 10.1073/pnas.90.4.1374 · DOI · Paper page
  5. Venturini, 1998, Up-regulation of peripheral benzodiazepine receptor system in hepatocellular carcinoma, Life Sci., 63, 1269, 10.1016/S0024-3205(98)00388-9 · DOI
  6. Hardwick, 1999, Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol, Cancer Res., 59, 831
  7. Olson, 1988, Presence of peripheral-type benzodiazepine binding sites on human erythrocyte membranes, Eur. J. Pharmacol., 152, 47, 10.1016/0014-2999(88)90834-5 · DOI
  8. Oke, 1992, Cell surface localization of the peripheral-type benzodiazepine receptor (PBR) in adrenal cortex, Mol. Cell. Endocrinol., 87, R1, 10.1016/0303-7207(92)90248-5 · DOI
  9. Antkiewicz-Michaluk, 1988, Molecular characterization and mitochondrial density of a recognition site for peripheral-type benzodiazepine ligands, Mol. Pharmacol., 34, 272
  10. Lacapere, 2001, Structural and functional study of reconstituted peripheral benzodiazepine receptor, Biochem. Biophys. Res. Commun., 284, 536, 10.1006/bbrc.2001.4975 · DOI · Paper page
  11. McEnery, 1992, Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier, Proc. Natl. Acad. Sci. U. S. A., 89, 3170, 10.1073/pnas.89.8.3170 · DOI · Paper page
  12. Galiegue, 1999, Cloning and characterization of PRAX-1. A new protein that specifically interacts with the peripheral benzodiazepine receptor, J. Biol. Chem., 274, 2938, 10.1074/jbc.274.5.2938 · DOI
  13. Li, 2001, Identification, localization, and function in steroidogenesis of PAP7: a peripheral-type benzodiazepine receptor- and PKA (RIα)-associated protein, Mol. Endocrinol., 15, 2211, 10.1210/me.15.12.2211 · DOI
  14. Golani, 2001, Hormonal regulation of peripheral benzodiazepine receptor binding properties is mediated by subunit interaction, Biochemistry, 40, 10213, 10.1021/bi010431+ · DOI
  15. Delavoie, 2003, In vivo and in vitro peripheral-type benzodiazepine receptor polymerization: functional significance in drug ligand and cholesterol binding, Biochemistry, 42, 4506, 10.1021/bi0267487 · DOI · Paper page
  16. Pedigo, 1981, Benzodiazepine receptor binding in young, mature and senescent rat brain and kidney, Neurobiol. Aging, 2, 83, 10.1016/0197-4580(81)90003-8 · DOI
  17. Le Fur, 1983, Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-(1-methylpropyl)-3 isoquinolinecarboxamide. II. In vivo studies, Life Sci., 32, 1849, 10.1016/0024-3205(83)90063-2 · DOI · Paper page
  18. Romeo, 1992, 2-Aryl-3-indoleacetamides (FGIN-1): a new class of potent and specific ligands for the mitochondrial DBI receptor (MDR), J. Pharmacol. Exp. Ther., 262, 971
  19. Campiani, 1996, Synthesis, biological activity, and SARs of pyrrolobenzoxazepine derivatives, a new class of specific ‘peripheral-type’ benzodiazepine receptor ligands, J. Med. Chem., 39, 3435, 10.1021/jm960251b · DOI
  20. Serra, 1999, 2-Phenyl-imidazo[1,2-a]pyridine derivatives as ligands for peripheral benzodiazepine receptors: stimulation of neurosteroid synthesis and anticonflict action in rats, Br. J. Pharmacol., 127, 177, 10.1038/sj.bjp.0702530 · DOI
  21. Culty, 2001, Peripheral benzodiazepine receptor binding properties and effects on steroid synthesis of two new phenoxyphenyl-acetamide derivatives, DAA1097 and DAA1106, Drug Dev. Res., 52, 475, 10.1002/ddr.1149 · DOI
  22. Trapani, 2005, Structure-activity relationships and effects on neuroactive steroid synthesis in a series of 2-phenylimidazo[1,2-a]pyridineacetamide peripheral benzodiazepine receptors ligands, J. Med. Chem., 48, 292, 10.1021/jm049610q · DOI
  23. Kita, 2004, Antianxiety and antidepressant-like effects of AC-5216, a novel mitochondrial benzodiazepine receptor ligand, Br. J. Pharmacol., 142, 1059, 10.1038/sj.bjp.0705681 · DOI
  24. Snyder, 1987, The peripheral-type benzodiazepine receptor: a protein of mitochondrial outer membranes utilizing porphyrins as endogenous ligands, FASEB J., 1, 282, 10.1096/fasebj.1.4.2820823 · DOI · Paper page
  25. Costa, 1994, The pharmacology of neurosteroidogenesis, J. Steroid Biochem. Mol. Biol., 49, 385, 10.1016/0960-0760(94)90284-4 · DOI
  26. Farges, 1993, Molecular basis for the different binding properties of benzodiazepines to human and bovine peripheral-type benzodiazepine receptors, FEBS Lett., 335, 305, 10.1016/0014-5793(93)80407-L · DOI
  27. Parola, 1991, The bovine peripheral-type benzodiazepine receptor: a receptor with low affinity for benzodiazepines, Life Sci., 48, 757, 10.1016/0024-3205(91)90090-X · DOI
  28. Papadopoulos, 2006, Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders, Neuroscience, 138, 749, 10.1016/j.neuroscience.2005.05.063 · DOI · Paper page
  29. Jamin, 2005, Characterization of the cholesterol recognition amino acid consensus sequence of the peripheral-type benzodiazepine receptor, Mol. Endocrinol., 19, 588, 10.1210/me.2004-0308 · DOI · Paper page
  30. Wright, 1999, The effects of superoxide and the peripheral benzodiazepine receptor ligands on the mitochondrial processing of manganese-dependent superoxide dismutase, Exp. Cell Res., 246, 443, 10.1006/excr.1998.4331 · DOI
  31. Yeliseev, 2000, TspO of Rhodobacter sphaeroides. A structural and functional model for the mammalian peripheral benzodiazepine receptor, J. Biol. Chem., 275, 5657, 10.1074/jbc.275.8.5657 · DOI
  32. O’Hara, 2002, Mitochondrial transduction of ocular teratogenesis during methylmercury exposure, Teratology, 65, 131, 10.1002/tera.10028 · DOI
  33. Ostuni, 2004, Functional characterization and expression of PBR in rat gastric mucosa: stimulation of chloride secretion by PBR ligands, Am. J. Physiol. Gastrointest. Liver Physiol., 286, G1069, 10.1152/ajpgi.00290.2003 · DOI
  34. Faure, 2003, Evidence for a protective role of trimetazidine during cold ischemia: targeting inflammation and nephron mass, Biochem. Pharmacol., 66, 2241, 10.1016/j.bcp.2003.07.011 · DOI
  35. Torres, 2000, Anti-inflammatory effects of peripheral benzodiazepine receptor ligands in two mouse models of inflammation, Eur. J. Pharmacol., 408, 199, 10.1016/S0014-2999(00)00760-3 · DOI
  36. Larcher, 1989, Effects of peripheral benzodiazepines upon the O2 consumption of neuroblastoma cells, Eur. J. Pharmacol., 161, 197, 10.1016/0014-2999(89)90843-1 · DOI
  37. O’Hara, 2003, Mitochondrial benzodiazepine receptors regulate oxygen homeostasis in the early mouse embryo, Reprod. Toxicol., 17, 365, 10.1016/S0890-6238(03)00035-2 · DOI
  38. Charlap, 2003, Exposure–disease continuum for 2-chloro-2′-deoxyadenosine, a prototype ocular teratogen. 3. Intervention with PK11195, Birth Defects Res. A. Clin. Mol. Teratol., 67, 108, 10.1002/bdra.10026 · DOI
  39. Faure, 2002, Polyethylene glycol reduces early and long-term cold ischemia–reperfusion and renal medulla injury, J. Pharmacol. Exp. Ther., 302, 861, 10.1124/jpet.102.033688 · DOI
  40. Hauet, 2002, Modulation of peripheral-type benzodiazepine receptor levels in a reperfusion injury pig kidney-graft model, Transplantation, 74, 1507, 10.1097/00007890-200212150-00006 · DOI
  41. Ducis, 1990, The benzodiazepine receptor in cultured astrocytes from genetically epilepsy-prone rats, Brain Res., 531, 318, 10.1016/0006-8993(90)90793-B · doi:10.1016/0006-8993(90)90793-b
  42. Leonelli, 2005, Ro5-4864, a synthetic ligand of peripheral benzodiazepine receptor, reduces aging associated myelin degeneration in the sciatic nerve of male rats, Mech. Ageing Dev., 126, 1159, 10.1016/j.mad.2005.06.001 · DOI
  43. Soreni, 1999, Decreased platelet peripheral-type benzodiazepine receptors in adolescent inpatients with repeated suicide attempts, Biol. Psychiatry, 46, 484, 10.1016/S0006-3223(98)00342-4 · DOI
  44. van Kammen, 1993, CSF diazepam binding inhibitor and schizophrenia: clinical and biochemical relationships, Biol. Psychiatry, 34, 515, 10.1016/0006-3223(93)90193-H · DOI
  45. Ritsner, 2003, Decreased platelet peripheral-type benzodiazepine receptors in persistently violent schizophrenia patients, J. Psychiatr. Res., 37, 549, 10.1016/S0022-3956(03)00055-4 · DOI
  46. Maaser, 2001, Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human colorectal cancer cells, Br. J. Cancer, 85, 1771, 10.1054/bjoc.2001.2181 · DOI
  47. Maaser, 2002, Overexpression of the peripheral benzodiazepine receptor is a relevant prognostic factor in stage III colorectal cancer, Clin. Cancer Res., 8, 3205
  48. Han, 2003, Expression of peripheral benzodiazepine receptor (PBR) in human tumors: relationship to breast, colorectal, and prostate tumor progression, J. Recept. Signal Transduct. Res., 23, 225, 10.1081/RRS-120025210 · DOI
  49. Galiegue, 2004, Immunohistochemical assessment of the peripheral benzodiazepine receptor in breast cancer and its relationship with survival, Clin. Cancer Res., 10, 2058, 10.1158/1078-0432.CCR-03-0988 · DOI
  50. Kletsas, 2004, Peripheral-type benzodiazepine receptor (PBR) and PBR drug ligands in fibroblast and fibrosarcoma cell proliferation: role of ERK, c-Jun and ligand-activated PBR-independent pathways, Biochem. Pharmacol., 67, 1927, 10.1016/j.bcp.2004.01.021 · DOI
  51. Weisinger, 2004, Peripheral benzodiazepine receptor antisense knockout increases tumorigenicity of MA-10 Leydig cells in vivo and in vitro, Biochemistry, 43, 12315, 10.1021/bi030251v · DOI
  52. Ravagnan, 1999, Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore, Oncogene, 18, 2537, 10.1038/sj.onc.1202625 · DOI · Paper page
  53. Cagnin, 2001, In vivo measurement of activated microglia in dementia, Lancet, 358, 461, 10.1016/S0140-6736(01)05625-2 · DOI · Paper page
  54. Zhang, 2004, Development of a new radioligand, N-(5-fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoroethyl-5-methoxybenzyl)acetamide, for PET imaging of peripheral benzodiazepine receptor in primate brain, J. Med. Chem., 47, 2228, 10.1021/jm0304919 · DOI
  55. Chen, 2004, Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization, Brain, 127, 1379, 10.1093/brain/awh161 · DOI
  56. Hans, 2005, Peripheral benzodiazepine receptor (PBR) ligand cytotoxicity unrelated to PBR expression, Biochem. Pharmacol., 69, 819, 10.1016/j.bcp.2004.11.029 · DOI
  57. Veenman, 2006, The peripheral-type benzodiazepine receptor and the cardiovascular system: implications for drug development, Pharmacol. Ther., 110, 503, 10.1016/j.pharmthera.2005.09.007 · DOI · Paper page
  58. Veenman, 2002, PK 11195 attenuates kainic acid-induced seizures and alterations in peripheral-type benzodiazepine receptor (PBR) components in the rat brain, J. Neurochem., 80, 917, 10.1046/j.0022-3042.2002.00769.x · DOI

Cited by

See all 1,389

Metadata

Authors
Papadopoulos, V., Baraldi, M., Guilarte, T. R., Knudsen, T. B., Lacapère, J.-J., Lindemann, P., Norenberg, M. D., Nutt, D., Weizman, A., Zhang, M.-R., & Gavish, M.
Venue
Trends in Pharmacological Sciences
Publisher
Elsevier BV
Published
2006-08
Volume
27
Issue
8
Pages
402-409
ISSN
0165-6147 (ISSN-L)
DOI
10.1016/j.tips.2006.06.005
OpenAlex
W2034450620
Cited by
1,389
References
6
FWCI
3.30
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.